Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer

Laryngoscope

Volumn 111, Issue 1, 2001, Pages 124-130

  Edström, Staffan ^a   Cvetkovska, Elisabet ^a   Westin, Thomas ^a   Young, Cecilia ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bromodeoxyuridine; Head and neck cancer; p53 tumor suppressor gene; Tumor growth

Indexed keywords

BROXURIDINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DO7; MONOCLONAL ANTIBODY PAB 1801; PROTEIN P53; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CELL KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENE OVEREXPRESSION; HEAD CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; METASTASIS; NECK CANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0035167734     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200101000-00022     Document Type: Article

References (53)

1. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony stimulating factor and contained CD34+ natural suppressor cells
2. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: A clinical-pathologic correlation
3. Mechanisms of immune suppression in patients with head and neck cancer: Presence of CD34+ cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor
4. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients
5. Malnutrition and food intake in relation to quality of life in head and neck cancer patients
6. DNA damage and p53-mediated cell cycle arrest: A reevaluation
7. p53 status and the efficacy of cancer therapy in vivo
8. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma
9. p53: Oncogene or anti-oncogene?
10. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck
11. Effects of nandrolone propionate on experimental tumor growth and cancer cachexia
12. A method to measure the DNA synthesis and the potential doubling time from a single sample
13. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression
14. p53 status of head and neck cancer: Relation to biological characteristics and outcome of radiotherapy
15. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck
16. Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer
17. Immunohistochemical detection of the p53 oncoprotein in tumours of melanocytic origin
18. Mutation and expression of the p53 gene in malignant melanoma cell lines
19. p53 immunohistochemistry: A word of caution
20. Activation of hypoxia-induced, transcriptionally latent p53 by DNA damage
21. PCNA, Ki-67, p53, bcl-2 and prognosis in intraoral squamous cell carcinoma of the head and neck
22. Bcl-2 and p53 expressions in invasive bladder cancers
23. Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder
24. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis
25. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
26. TP53 mutation and P53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients
27. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of nonsmall cell lung cancer
28. The complexities of proliferating cell nuclear antigen
29. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
30. Proliferative pattern of head neck cancer
31. Archival analysis of p53 genetic and protein alteration in Chinese oesophageal cancer
32. The incidence of p53 mutation increases with progression of head and neck cancer
33. Clinical implications of the p53 tumor-suppressor gene
34. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
35. Accumulation of nuclear p53 and tumor progression in bladder cancer
36. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study
37. A evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma
38. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck
39. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy
40. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: Clinicopathological associations
41. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma
42. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors
43. Ki-67 and p53 in T2 laryngeal cancer
44. p53 overexpression correlates with proliferative activity and prognosis in carcinomas of the pyriform sinus
45. Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?
46. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks
47. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines
48. p53 and the behaviour of colorectal cancer
49. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions
50. p53 and retinoid chemoprevention of oral carcinogenesis
51. The incidence of p53 mutations increases with progression of head and neck cancer
52. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor suppressor genes
53. The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers